Stiles Financial Services’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,181
Closed -$189K 192
2024
Q3
$189K Hold
10,181
0.07% 184
2024
Q2
$157K Hold
10,181
0.06% 181
2024
Q1
$150K Hold
10,181
0.06% 172
2023
Q4
$145K Sell
10,181
-2,452
-19% -$34.8K 0.07% 165
2023
Q3
$176K Buy
12,633
+59
+0.5% +$755 0.09% 168
2023
Q2
$148K Buy
12,574
+67
+0.5% +$763 0.07% 185
2023
Q1
$144K Buy
12,507
+56
+0.4% +$693 0.08% 177
2022
Q4
$155K Buy
12,451
+288
+2% +$3.67K 0.09% 170
2022
Q3
$160K Buy
12,163
+233
+2% +$3.44K 0.1% 160
2022
Q2
$167K Buy
11,930
+251
+2% +$3.36K 0.1% 165
2022
Q1
$174K Buy
11,679
+267
+2% +$3.65K 0.09% 179
2021
Q4
$155K Buy
+11,412
New +$161K 0.07% 181

Other funds holding SBRA

Stiles Financial Services's SBRA Position: Q4 2024 in Review

Stiles Financial Services sold out of Sabra Healthcare REIT (SBRA) in Q4 2024, closing a stake of 10,181 shares — an estimated $189K sold.

Stiles Financial Services first reported a position in SBRA in Q4 2021 and held it in 12 quarters. The position peaked at $189K in Q3 2024. 389 funds tracked by Wall St. Rank hold SBRA as of Q4 2024.

  • Stiles Financial Services reported no remaining Sabra Healthcare REIT position as of Q4 2024 after selling out during the quarter.
  • Stiles Financial Services sold 10,181 Sabra Healthcare REIT shares in Q4 2024, an estimated $189K.
  • Stiles Financial Services first reported a position in Sabra Healthcare REIT in Q4 2021 and held it in 12 quarters.
  • Stiles Financial Services's Sabra Healthcare REIT position peaked at $189K in Q3 2024.
  • 389 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2024.

Based on Stiles Financial Services's 13F filing for Q4 2024, filed 28 Jan 2025.